Evidence map›Paper›PMID 41807716›Full record

ArticleScientific reports2026

HIF3A-mediated aberrant activation of TXNIP promotes Alzheimer's disease progression.

Meng Xue, Wuzhou Zheng, Fang Li, Lina Gao, Xiaoxiao Jia, Siliang Pang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meng XueNeurology Department, Yellow River Sanmenxia Hospital, Sanmenxia, Henan Province, China. xuemeng5200204@163.com.
Wuzhou ZhengEncephalopathy Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
Fang LiNeurology Department, Yellow River Sanmenxia Hospital, Sanmenxia, Henan Province, China.
Lina GaoNeurology Department, Yellow River Sanmenxia Hospital, Sanmenxia, Henan Province, China.
Xiaoxiao JiaNeurology Department, Yellow River Sanmenxia Hospital, Sanmenxia, Henan Province, China.
Siliang PangNeurology Department, Yellow River Sanmenxia Hospital, Sanmenxia, Henan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress (OS) is a hallmark of Alzheimer's disease (AD), yet the cell type-specific mechanisms remain unclear. We analyzed a single-cell RNA sequencing (scRNA-seq) dataset to assess OS-related features in AD. OS scores were calculated using multiple algorithms, and differential expression, enrichment, protein-protein interaction (PPI) network, and machine learning (ML) approaches were applied to identify key genes. Validation was performed at both bulk and single-cell levels, and functional assays were conducted to elucidate molecular mechanisms. OS activity was significantly elevated in AD, with pronounced heterogeneity across cell types. Astrocytes exhibited the highest OS activity, and their proportion was markedly reduced in AD. We identified 54 OS-upregulated genes enriched in neurodevelopment and synaptic processes. Through integrative ML, HIF3A was pinpointed as a key OS-related gene, showing high expression in astrocytes and strong correlation with OS pathways. Mechanistically, HIF3A directly bound to the TXNIP promoter, upregulated TXNIP expression, and thereby enhanced mitochondrial ROS production, impaired energy metabolism, and exacerbated OS in astrocytes. Our findings reveal that astrocytic HIF3A mediates aberrant OS responses in AD via transcriptional upregulation of TXNIP, offering insights into potential therapeutic targets to mitigate oxidative damage in AD.

Indexed as

Alzheimer DiseaseBasic Helix-Loop-Helix ProteinsCarrier ProteinsPoly(A)-Binding ProteinsAnimalsAstrocytesDisease ProgressionHumansMitochondriaOxidative StressReactive Oxygen SpeciesUp-RegulationBasic Helix-Loop-Helix ProteinsCarrier ProteinsPoly(A)-Binding ProteinsReactive Oxygen SpeciesTXNIP protein, humanAlzheimer’s diseaseAstrocytesHIF3AOxidative stressTXNIP

Identifiers

PMID41807716
PMCPMC13096512

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.